13:20 Mon 03 Sep 2018
Collagen Sol PLC - Director/PDMR Shareholding
(the "Company" or the "Group")
Director/PDMR Dealing
The Company today announces that on
Following these purchases,
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
|
|
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Chief Operating Officer |
||||
b) |
Initial notification / Amendment |
Initial |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
|
|
||||
b) |
LEI |
213800IFY1CVGRGETL95 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each |
||||
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information |
|
||||
e) |
Date of the transaction |
|
||||
f) |
Place of the transaction |
|
Enquiries:
|
|
||
|
Via Walbrook |
||
|
|
||
|
|
||
Cenkos Securities Plc (Nominated Adviser and Broker) |
|
||
|
Tel: 0207 397 8900 |
||
|
|
||
|
|
||
|
Tel: 020 7933 8780 or collagen@walbrookpr.com |
||
|
Mob: 07876 741 001 |
||
|
Mob: 07841 917 679 |
||
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE